NAPROGENIX, INC

Basic Information

KTRDC - U.K. - AgTecc Laboratories
Lexington, KY, 40546-0236

http://www.naprogenix.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 196165877
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 8


  1. Novel flavonoids as anti-inflammatory agents in alcoholism

    Amount: $150,900.00

    DESCRIPTION (provided by applicant): Flavonoids are ubiquitous secondary metabolites in plants with many known health benefits, which are mostly ascribed to their potent anti-oxidant activity. Howev ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Harvesting specific plant metabolites from hairy root cultures using magnetized n

    Amount: $189,844.00

    DESCRIPTION: Plants produce a wide variety of valuable bioactive metabolites, but these are commonly present in low concentrations in the wild-type plant. This makes the separation and purification o ...

    STTR Phase I 2014 Department of Health and Human Services
  3. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $1,019,366.00

    DESCRIPTION (provided by applicant): This project aims to demonstrate that the evolution of plant biosynthetic pathways can be accelerated and driven to favor the synthesis of ligands which interact w ...

    SBIR Phase II 2013 Department of Health and Human Services
  4. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $1,102,755.00

    DESCRIPTION provided by applicant This project aims to demonstrate that the evolution of plant biosynthetic pathways can be accelerated and driven to favor the synthesis of ligands which interact w ...

    SBIR Phase II 2013 Department of Health and Human Services National Institutes of Health
  5. NOVEL PHARMACOTHERAPIES FOR ALCOHOLISM, TOPIC #4409/24/2012- 03/23/2013

    Amount: $149,697.00

    Alcoholism is a complex condition in which there are many potential molecular and therapeutic targets for pharmacotherapy. This fast track SBIR contract aims to investigate compounds targeted on t ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $272,674.00

    DESCRIPTION (provided by applicant): The primary aim is to transfer a biotechnology platform for plant drug discovery from the academic laboratory to industry use (i.e. this application is directly re ...

    SBIR Phase I 2010 Department of Health and Human Services
  7. Novel estrogen receptor ligands from plant genomics

    Amount: $699,216.00

    DESCRIPTION (provided by applicant): Human nuclear receptor (HNR) ligands have potential value as pharmacotherapies or chemopreventive agents for many hormone-responsive cancers. The primary aim of th ...

    STTR Phase II 2010 Department of Health and Human Services
  8. Potential anti-relapse drugs: a plant genomics approach

    Amount: $340,250.00

    DESCRIPTION (provided by applicant): Alcohol-induced neurodegeneration and the consequent dementia are important therapeutic targets in alcoholism. However, because alcohol-induced neurotoxicity has ...

    STTR Phase II 2008 Department of Health and Human Services
  9. Transgenic plant cells as a source of hepatoprotective drugs

    Amount: $249,230.00

    DESCRIPTION (provided by applicant): Alcoholic liver damage (ALD) is among the top ten causes of death in the USA, but existing therapeutic interventions are relatively ineffective. Hepatocytes are su ...

    STTR Phase II 2007 Department of Health and Human Services
  10. Hypericum extracts as potential anti-relapse medications in alcoholism

    Amount: $1,128,279.00

    DESCRIPTION (provided by applicant): Alcoholism is a complex disease and anti-relapse treatments should recognize this. For example, depression is a frequent precipitant of relapse (1) and is the most ...

    STTR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government